Discover 1,294 paid clinical trials in Surprise, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,294
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
for
Relapsed or Refractory Multiple Myeloma
Location: Phoenix AZ, Orange CA, Rochester MN, Nashville TN,
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT06375044
Phase 1, Recruiting
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
for
Prostate Cancer, Prostatic Neoplasms
Location: Phoenix AZ, Orange CA, Los Angeles CA, Murray UT,
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male
Age: 18+
Code: NCT06056830
Phase 3, Recruiting
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
for
Endometrial Cancer, Cervical Cancer,
Location: Phoenix AZ, Katy TX, Houston TX, Grand Forks ND,
Sponsor: Mayo Clinic
Sex: Female
Age: 18+
Code: NCT05051722
Recruiting
Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
Location: Phoenix AZ, Houston TX, Seattle WA, Rochester MN,
Sponsor: Epigenetix, Inc.
Sex: All
Age: 18+
Code: NCT05488548
Phase 1, Recruiting
Low Sodium Oxybate in Patients With Idiopathic Hypersomnia
for
Idiopathic Hypersomnia
Location: Phoenix AZ, Redwood City CA, Jacksonville FL, Boston MA
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 65
Code: NCT05837091
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Phoenix AZ, Tucson AZ, Murrieta CA, Orange CA,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06510374
Phase 3, Recruiting
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
for
Metastatic Digestive System Neuroendocrine Tumor G1,
Location: Phoenix AZ, Tucson AZ, Albuquerque NM,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05773274
Phase 2, Recruiting
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Phoenix AZ, La Jolla CA, Irvine CA, Sacramento CA,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06706076
Phase 1, Phase 2, Recruiting
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
for
Solid Tumors
Location: Phoenix AZ, Santa Monica CA, Palo Alto CA, Houston TX,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06179160
Phase 1, Recruiting
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
for
Glioblastoma, Recurrent Glioblastoma, GBM
Location: Phoenix AZ, Salt Lake City UT, Aurora CO,
Sponsor: CarThera
Sex: All
Age: 18+
Code: NCT05902169
Phase 3, Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Phoenix AZ, Irvine CA, Orange CA, Beverly Hills CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07518186
Phase 3, Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
for
Atopic Dermatitis, Eczema, Atopic
Location: Phoenix AZ, Scottsdale AZ, Huntington Beach CA,
Sponsor: Pfizer
Sex: All
Age: 18 - 64
Code: NCT07216027
Phase 2, Recruiting
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
for
Meningioma
Location: Phoenix AZ, Santa Monica CA, San Francisco CA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07428616
Phase 2, Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Phoenix AZ, Tucson AZ, Irvine CA, Orange CA, Duarte CA,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase 3, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
for
Recurrent Glioblastoma, IDH-Wildtype,
Location: Phoenix AZ, La Jolla CA, Irvine CA, Orange CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05432804
Phase 1, Phase 2, Recruiting
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
for
Glioblastoma (GBM)
Location: Phoenix AZ, Rochester MN, Jacksonville FL
Sponsor: Myosin Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT07185880
Phase 1, Phase 2, Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Phoenix AZ, Irvine CA, Duarte CA, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase 3, Recruiting
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: Phoenix AZ, St Louis MO, Rochester MN, Jacksonville FL,
Sponsor: BicycleTx Limited
Sex: All
Age: 18+
Code: NCT07450859
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Phoenix AZ, Orange CA, Los Angeles CA, Amarillo TX,